Registry Study of Revcovi Treatment in Patients With ADA-SCID

NCT03878069 · clinicaltrials.gov ↗

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Adenosine Deaminase Severe Combined Immunodeficiency

Interventions

BIOLOGICAL: elapegademase-lvlr

Sponsor

Chiesi Farmaceutici S.p.A.